2. Signaling Pathways
  3. Apoptosis
  4. Cuproptosis
  5. Cuproptosis Inhibitor

Cuproptosis Inhibitor

Cuproptosis Inhibitors (7):

Cat. No. Product Name Effect Purity
  • HY-W076067
    Ammonium tetrathiomolybdate(VI)
    		Inhibitor 99.99%
    Ammonium tetrathiomolybdate(VI) is a copper chelator and also is a class of sulfide donor. Ammonium tetrathiomolybdate(VI) has neuroprotection effects. Ammonium tetrathiomolybdate(VI) can be used for the research of brain ischemia.
  • HY-B0300
    Penicillamine
    		Inhibitor ≥98.0%
    Penicillamine (D-(-)-Penicillamine) is a penicillin metabolic degradation product, can be used as a heavy metal chelator. Penicillamine reduces free copper and reduces oxidative stress. Penicillamine has effect of seizures through nitric oxide/NMDA pathways. Penicillamine is a potential immune modulator. Penicillamine can be used for the research of Wilson disease, rheumatoid arthritis, and cystinuria.
  • HY-156780
    NSC 689534
    		Inhibitor
    NSC 689534 can form copper chelate with Cu2+. NSC 689534/Cu2+ complex is a potent oxidative stress inducer, and has antitumor activity.
  • HY-163200
    Cu(I) chelator 1
    		Inhibitor
    Cu(I) chelator 1 (Compound LH2) is a chelator which targets the Cu(I) redox state. Cu(I) chelator 1 prevents ROS production.
  • HY-16739
    Emeramide
    		Inhibitor 99.56%
    Emeramide is a thiol-redox antioxidant and heavy metal chelator.
  • HY-B0300S
    Penicillamine-d3
    		Inhibitor
    Penicillamine-d3 is the deuterium labeled Penicillamine. Penicillamine (D-(-)-Penicillamine) is the most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
  • HY-128530
    Tetrathiomolybdate
    		Inhibitor
    Tetrathiomolybdate, an orally active anti-copper agent, reduces copper levels in the body. Tetrathiomolybdate has a protective effect on collagen-induced arthritis in mice. Tetrathiomolybdate also reduces blood sugar, but has no effect on mice with hereditary diabetes (db/db). Tetrathiomolybdate inhibit angiogenesis, also shows antiangiogenic effects in malignant pleural mesothelioma.